GlycoDiagnostics
PrivateCompany Overview
GlycoDiagnostics is a biotechnology company developing a non-invasive blood test for the early detection of liver fibrosis using glycan biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
liver fibrosisdiagnostic blood testglycan biomarkersliquid biopsynon-invasive diagnosticsliver diseasebiotechnologyprecision medicineearly detectionclinical diagnosticsmetabolic liver diseaseglycomicsbiomarker discoveryclinical trialdiagnostic assay
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlycoDiagnostics Comparables
Compare GlycoDiagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioPredictive | 81% | |
| MetaDeq | 80% | |
| Fibronostics | 79% | |
GlycoDiagnostics Funding Rounds
Historical fundraising activity
GlycoDiagnostics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GlycoDiagnostics's valuation, stock price, and market status.